185 related articles for article (PubMed ID: 16875760)
1. Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication.
Li YQ; Li ZL; Zhao WJ; Wen RX; Meng QW; Zeng Y
Eur J Med Chem; 2006 Sep; 41(9):1084-9. PubMed ID: 16875760
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).
Chu CK; Gadthula S; Chen X; Choo H; Olgen S; Barnard DL; Sidwell RW
Antivir Chem Chemother; 2006; 17(5):285-9. PubMed ID: 17176633
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
Saijo M; Morikawa S; Fukushi S; Mizutani T; Hasegawa H; Nagata N; Iwata N; Kurane I
Antiviral Res; 2005 Jun; 66(2-3):159-63. PubMed ID: 15911031
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta 1a and SARS coronavirus replication.
Hensley LE; Fritz LE; Jahrling PB; Karp CL; Huggins JW; Geisbert TW
Emerg Infect Dis; 2004 Feb; 10(2):317-9. PubMed ID: 15030704
[TBL] [Abstract][Full Text] [Related]
5. The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein.
Spiegel M; Pichlmair A; Mühlberger E; Haller O; Weber F
J Clin Virol; 2004 Jul; 30(3):211-3. PubMed ID: 15135736
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide.
Wu CJ; Jan JT; Chen CM; Hsieh HP; Hwang DR; Liu HW; Liu CY; Huang HW; Chen SC; Hong CF; Lin RK; Chao YS; Hsu JT
Antimicrob Agents Chemother; 2004 Jul; 48(7):2693-6. PubMed ID: 15215127
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition of SARS virus replication by human interferons.
Dahl H; Linde A; Strannegård O
Scand J Infect Dis; 2004; 36(11-12):829-31. PubMed ID: 15764169
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.
Hoever G; Baltina L; Michaelis M; Kondratenko R; Baltina L; Tolstikov GA; Doerr HW; Cinatl J
J Med Chem; 2005 Feb; 48(4):1256-9. PubMed ID: 15715493
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.
Akerström S; Mousavi-Jazi M; Klingström J; Leijon M; Lundkvist A; Mirazimi A
J Virol; 2005 Feb; 79(3):1966-9. PubMed ID: 15650225
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
Sainz B; Mossel EC; Peters CJ; Garry RF
Virology; 2004 Nov; 329(1):11-7. PubMed ID: 15476870
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of SARS-CoV replication by siRNA.
Wu CJ; Huang HW; Liu CY; Hong CF; Chan YL
Antiviral Res; 2005 Jan; 65(1):45-8. PubMed ID: 15652970
[TBL] [Abstract][Full Text] [Related]
12. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain.
Schneider M; Ackermann K; Stuart M; Wex C; Protzer U; Schätzl HM; Gilch S
J Virol; 2012 Sep; 86(18):10112-22. PubMed ID: 22787216
[TBL] [Abstract][Full Text] [Related]
13. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
[TBL] [Abstract][Full Text] [Related]
14. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus.
Yamamoto N; Yang R; Yoshinaka Y; Amari S; Nakano T; Cinatl J; Rabenau H; Doerr HW; Hunsmann G; Otaka A; Tamamura H; Fujii N; Yamamoto N
Biochem Biophys Res Commun; 2004 Jun; 318(3):719-25. PubMed ID: 15144898
[TBL] [Abstract][Full Text] [Related]
15. siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero E6 cells.
Lu CY; Huang HY; Yang TH; Chang LY; Lee CY; Huang LM
Eur J Clin Microbiol Infect Dis; 2008 Aug; 27(8):709-15. PubMed ID: 18449585
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells.
Wang Z; Ren L; Zhao X; Hung T; Meng A; Wang J; Chen YG
J Virol; 2004 Jul; 78(14):7523-7. PubMed ID: 15220426
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons.
Scagnolari C; Vicenzi E; Bellomi F; Stillitano MG; Pinna D; Poli G; Clementi M; Dianzani F; Antonelli G
Antivir Ther; 2004 Dec; 9(6):1003-11. PubMed ID: 15651759
[TBL] [Abstract][Full Text] [Related]
18. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines.
Morgenstern B; Michaelis M; Baer PC; Doerr HW; Cinatl J
Biochem Biophys Res Commun; 2005 Jan; 326(4):905-8. PubMed ID: 15607755
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
Kao RY; Tsui WH; Lee TS; Tanner JA; Watt RM; Huang JD; Hu L; Chen G; Chen Z; Zhang L; He T; Chan KH; Tse H; To AP; Ng LW; Wong BC; Tsoi HW; Yang D; Ho DD; Yuen KY
Chem Biol; 2004 Sep; 11(9):1293-9. PubMed ID: 15380189
[TBL] [Abstract][Full Text] [Related]
20. Helicases as antiviral drug targets.
Huang JD; Zheng BJ; Sun HZ
Hong Kong Med J; 2008 Aug; 14 Suppl 4():36-8. PubMed ID: 18708673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
